SEC Form 4 · accession 0001171843-19-001414
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph G Darling
Officer — President and CEO; Director · Director
Period of report
Feb 28, 2019
Accepted (ET)
Mar 1, 2019 · 8:30 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 28, 2019 | P | 1,000 | $33.20 | A | 22,436 | D |
Table II — derivative securities
No Table II lines on this filing.